RecruitingNCT06446778

Pipeline Embolization for Intracranial Aneurysms

Pipeline Embolization Device for Intracranial Aneurysm (PEDIA): a Prospective, Multicenter Cohort Focus on Safety, Efficacy, and Haemodynamics


Sponsor

Zhujiang Hospital

Enrollment

1,000 participants

Start Date

Sep 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This study collected the clinical, laboratory, and imaging data from patients with intracranial aneurysms, who underwent Pipeline implantation. The purpose of this study is to observe the safety, effcacy, and haemodynamics after Pipeline embolization.


Eligibility

Min Age: 22 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Pipeline embolization device with or without shield technique for people with aneurysm, intracranial, efficacy, self, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPipeline embolization device with or without shield technique

The patients undenwent Pipeline embolization device implantation with or without shield technique due to market availability, choice and preferences of the surgeon.


Locations(1)

Zhujiang hospital

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06446778


Related Trials